Current treatment of unresectable lung cancerJETT, J. R.Mayo Clinic proceedings. 1993, Vol 68, Num 6, pp 603-611, issn 0025-6196Article

Is there a role for interferon in the treatment of small cell lung cancer?JETT, J. R.Lung cancer. 1989, Vol 5, Num 4-6, pp 281-286, issn 0169-5002, 6 p.Conference Paper

Superior pulmonary sulcus tumors and Pancoast's syndromeARCASOY, S. M; JETT, J. R.The New England journal of medicine. 1997, Vol 337, Num 19, pp 1370-1376, issn 0028-4793Article

Treatment of non-small-cell lung cancerHADEED, V. A; JETT, J. R.Comprehensive therapy. 1996, Vol 22, Num 10, pp 641-648, issn 0098-8243Article

Lung cancer in the elderlyJETT, J. R; TAZELAAR, H. D.Lung biology in health and disease. 1993, Vol 63, pp 239-277, issn 0362-3181Article

Lung cancer: the American viewSANDERSON, D. R; JETT, J. R.The European respiratory journal. 1989, Vol 2, Num 10, pp 1002-1007, issn 0903-1936Conference Paper

A phase I-II study of sequential infusion VP-16 and cisplatin therapy in advanced lung cancerKROOK, J. E; JETT, J. R; LITTLE, C et al.American journal of clinical oncology. 1989, Vol 12, Num 2, pp 114-117, issn 0277-3732Article

A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer : a CALGB and NCCTG studyDY, G. K; MILLER, A. A; MANDREKAR, S. J et al.Annals of oncology. 2005, Vol 16, Num 11, pp 1811-1816, issn 0923-7534, 6 p.Article

Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung Cancer : A phase II study of the North Central Cancer Treatment GroupKIRSCHLING, R. J; GRILL, J. P; MARKS, R. S et al.American journal of clinical oncology. 1999, Vol 22, Num 5, pp 517-522, issn 0277-3732Article

Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinomaBONNER, J. A; SLOAN, J. A; TAZELAAR, H. D et al.Journal of clinical oncology. 1999, Vol 17, Num 9, pp 2681-2691, issn 0732-183XConference Paper

The current management of thymic tumorsLUKETICH, J. D; JETT, J. R.Seminars in respiratory and critical care medicine. 1997, Vol 18, Num 4, pp 375-381, issn 1069-3424Article

p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancerPRZYGODZKI, R. M; BENNETT, W. P; TRASTEK, V et al.Pharmacogenetics (London). 1998, Vol 8, Num 6, pp 503-511, issn 0960-314XArticle

Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer : a randomized, phase III trialMORTON, R. F; JETT, J. R; DRUMMOND, R. G et al.Annals of internal medicine. 1991, Vol 115, Num 9, pp 681-686, issn 0003-4819Article

Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiationFRYTAK, S; SHAW, J. N; O'NEILL, B. P et al.American journal of clinical oncology. 1989, Vol 12, Num 1, pp 27-33, issn 0277-3732Article

Results of combination chemotherapy and thoracic radiation therapy for unresectable non-small cell carcinoma of the lungROBINOW, J. S; SHAW, E. G; EAGAN, R. T et al.International journal of radiation oncology, biology, physics. 1989, Vol 17, Num 6, pp 1203-1210, issn 0360-3016Conference Paper

Differences of host immune response and of sensitivity to chemotherapeutic agents between two clones of rat fibrosarcoma with different metastatic potentialFUTAMI, H; SAIJO, N; JETT, J. R et al.Japanese journal of cancer research. 1986, Vol 77, Num 5, pp 480-486, issn 0910-5050Article

Differing response rates and survival between squamous and non-squamous non-small cell lung cancer. Comparison of CAP versus MAPEAGAN, R. T; FRYTAK, S; CREAGAN, E. T et al.American journal of clinical oncology. 1986, Vol 9, Num 3, pp 249-254, issn 0277-3732Article

Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancerRAMALINGAM, S; BELANI, C. P; DAY, R et al.Annals of oncology. 2004, Vol 15, Num 2, pp 247-251, issn 0923-7534, 5 p.Article

Primary mediastinal tumors. Part II. Tumors of the middle and posterior mediastinumSTROLLO, D. C; ROSADO-DE-CHRISTENSON, M. L; JETT, J. R et al.Chest. 1997, Vol 112, Num 5, pp 1344-1357, issn 0012-3692Article

A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer : a trial of the North Central cancer Treatment GroupGESME, D. H; JETT, J. R; PFEIFLE, D. M et al.Cancer. 1993, Vol 71, Num 9, pp 2723-2726, issn 0008-543XArticle

Approach to the solitary pulmonary noduleMIDTHUN, D. E; SWENSEN, S. J; JETT, J. R et al.Mayo Clinic proceedings. 1993, Vol 68, Num 4, pp 378-385, issn 0025-6196Conference Paper

Plastic bronchitis : an old disease revisitedJETT, J. R; TAZELAAR, H. D; KEIM, L. W et al.Mayo Clinic proceedings. 1991, Vol 66, Num 3, pp 305-311, issn 0025-6196Article

The different effects of recombinant human tumor necrosis factor on rat fibrosarcoma sublinesISHIHARA, J; SAIJO, N; HOSHI, A et al.Cancer immunology and immunotherapy. 1987, Vol 24, Num 3, pp 185-189, issn 0340-7004Article

Erdheim-Chester disease: Clinical, radiologic, and histopathologic findings in five patients with interstitial lung diseaseEGAN, A. J. M; BOARDMAN, L. A; TAZELAAR, H. D et al.The American journal of surgical pathology. 1999, Vol 23, Num 1, pp 17-26, issn 0147-5185Article

New agents in the treatment of small cell lung cancerGHAEMMAGHAMI, M; JETT, J. R.Chest. 1998, Vol 113, Num 1, pp 86S-91S, issn 0012-3692, SUPConference Paper